Feb 23, 2024 · The goals of hypertrophic cardiomyopathy treatment are to ease symptoms and prevent sudden cardiac death in people at high risk. Treatment depends on how severe the symptoms are. If you have cardiomyopathy and are pregnant or thinking about pregnancy, talk with your healthcare professional.

Nov 20, 2020 · The purpose of this new guideline is to commission a full guideline revision of the previous “2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy.” 1 The current version will replace the 2011 guideline and addresses comprehensive evaluation and management of adults and children with hypertrophic ...

Hypertrophic cardiomyopathy (HCM) is a disease that involves the thickening of your heart muscle. Most people with HCM can live a normal life. Treatments are available.

May 29, 2024 · Treatment and management of HCM. There is currently only one disease-specific medication to treat hypertrophic cardiomyopathy. Mavacamten is used to treat the obstructive form of HCM in people who have symptoms.

Cardiac myosin inhibitors are now available to treat patients with symptomatic obstructive HCM. This new class of medication inhibits actin-myosin interaction, thus decreasing cardiac contractility and reducing left ventricular outflow tract obstruction. Mavacamten is currently the only U.S. Food and Drug Administration–approved agent.

Feb 21, 2024 · If you can't exercise, you may be given medicine that increases the heart rate like exercise does. Sometimes echocardiogram is done during a stress test. Cardiac catheterization. A thin tube called a catheter is placed into the groin and …

Nov 20, 2020 · This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use.

AIM: This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to …

Nov 20, 2020 · This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy.

Dr. Ommen: For patients who have symptoms due to hypertrophic cardiomyopathy, the first line of therapy is always to use medical management, medications. Usually, that's adding specific medications, but sometimes patients are on medications that can make their situation worse.